Cargando…

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

Major depressive disorder (MDD) is a leading cause of disability worldwide. Current first line therapies target modulation of the monoamine system. A large variety of agents are currently available that effectively alter monoamine levels; however, approximately one third of MDD patients remain treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenblat, Christian, McIntyre, Roger S., Alves, Gilberto S., Fountoulakis, Konstantinos N., Carvalho, André F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761634/ https://www.ncbi.nlm.nih.gov/pubmed/26467412 http://dx.doi.org/10.2174/1570159X13666150630175044

Ejemplares similares

Autobiographical Memory Disturbances in Depression: A Novel Therapeutic Target?
por: Köhler, Cristiano A., et al.
Publicado: (2015)

From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
por: Fountoulakis, Konstantinos N., et al.
Publicado: (2015)

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Rosenblat, Joshua D, et al.
Publicado: (2015)

Treatment Implications of Predominant Polarity and the Polarity Index: A Comprehensive Review
por: Carvalho, Andre F., et al.
Publicado: (2015)

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications
por: Rosenblat, Joshua D., et al.
Publicado: (2017)

Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
por: Chávez-Castillo, Mervin, et al.
Publicado: (2019)

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients
por: Woo, Young Sup, et al.
Publicado: (2016)

Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones
por: Wijaya, Chandra S., et al.
Publicado: (2018)

Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation
por: Webhofer, C, et al.
Publicado: (2011)

Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression
por: Marathe, Swananda V, et al.
Publicado: (2018)

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021)

A Vision for Drug Discovery and Development: Novel Targets and Multilateral Partnerships
por: McIntyre, Roger S.
Publicado: (2014)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022)

Unipolar late-onset depression: A comprehensive review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2003)

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
por: Renaud-Charest, Olivier, et al.
Publicado: (2021)

Pharmaceutical treatment of acute bipolar depression
por: Fountoulakis, Konstantinos N
Publicado: (2010)

Treatment guidelines for acute bipolar depression
por: Fountoulakis, Konstantinos N
Publicado: (2010)

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
por: Chisamore, Noah, et al.
Publicado: (2023)

The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
por: Bortolato, Beatrice, et al.
Publicado: (2015)

Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic
por: Rosenblat, Joshua D., et al.
Publicado: (2021)

Circadian rhythms: strong evidence on how to approach depression
por: Fountoulakis, Konstantinos N
Publicado: (2010)

Revisiting the Monoamine Hypothesis of Depression: A New Perspective
por: Goldberg, Joel S, et al.
Publicado: (2014)

Treatment-Resistant Depression in Primary Care Across Canada
por: Rizvi, Sakina J, et al.
Publicado: (2014)

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
por: McIntyre, Roger S., et al.
Publicado: (2020)

A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)
por: Rosenblat, Joshua D., et al.
Publicado: (2023)

Depression, anxiety and post-traumatic stress during the 2022 Russo-Ukrainian war, a comparison between populations in Poland, Ukraine, and Taiwan
por: Chudzicka-Czupała, Agata, et al.
Publicado: (2023)

Treatment-resistant Late-life Depression: Challenges and Perspectives
por: Knöchel, Christian, et al.
Publicado: (2015)

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
por: Baskaran, Anusha, et al.
Publicado: (2013)

Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
por: McIntyre, Roger S., et al.
Publicado: (2015)

Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders
por: Jiang, Yao, et al.
Publicado: (2022)

A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
por: McIntyre, Roger S., et al.
Publicado: (2014)

The discrediting of the monoamine hypothesis
por: Hinz, Marty, et al.
Publicado: (2012)

Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'
por: Fountoulakis, Konstantinos N
Publicado: (2010)

Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of "Rhythm-regulators"
por: Fountoulakis, Konstantinos N
Publicado: (2010)

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
por: McIntyre, Roger S, et al.
Publicado: (2022)

Is there a dysfunction in the visual system of depressed patients?
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2005)

Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials
por: McIntyre, R. S., et al.
Publicado: (2023)

Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression—An Animal Model Study
por: Malkesman, O., et al.
Publicado: (2009)

Associations Among Monoamine Neurotransmitter Pathways, Personality Traits, and Major Depressive Disorder
por: Shao, Xiaojun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k1hlia87nutm6tod8ks1e5pqig